← Browse by Condition
Medical Condition

oligometastatic prostate cancer ompc

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 3
NCT05939414 Phase 3
Recruiting

An Open-label Study Comparing Lutetium (177Lu) Vipivotide Tetraxetan Versus Observation in PSMA Positive OMPC.

Enrollment
450 pts
Location
United States, Argen...
Sponsor
Novartis Pharmaceuticals
View Trial →